Epidemiological studies can play an important role in identifying factors associated with risk of disease, manifestation of particular syndromes or poor survival. This can be of value in targeting prevention activities, as well directing further basic research, paving the way for the identification of novel therapeutic targets.
A European network Strep-EURO, launched in September 2002, provided an opportunity to explore epidemiological patterns across Europe. Twelve participants across eleven countries took part in the network, funded by the Fifth Framework Programme of the EU and co-ordinated by the University of Lund in Sweden.
Diseases caused by the Lancefield group A streptococcus, Streptococcus pyogenes, are amongst the most challenging to clinicians and public health specialists alike. This common bacterium of the throat and skin causes ‘strep throat’, skin infections, scarlet fever, and severe diseases such as pneumonia, septicaemia and necrotising fasciitis. Although severe infections caused by this organism are relatively uncommon, affecting around 3 per 100,000 of the population per annum in developed countries, the case fatality is high relative to many other infections.
This study arose from a new collaboration between the Health Protection Agency, the National Public Health Institute in Helsinki (KTL) and the University of Helsinki, Finland.
Theresa Lamagni, of the HPA provided the epidemiological lead for the Strep-EURO network, which succeeded in collecting a wealth of data on over 5000 cases identified over two years (2003-04). Analysis of these data has yielded important new information on the epidemiology of severe S. pyogenes infections in Europe during the 2000s. Comprehensive epidemiological data on these infections were obtained for the first time from France, Greece and Romania.
Incidence estimates identified a general north-south gradient, from high to low. Remarkably similar rates were observed among the three Nordic participants, between 2.2 and 2.3 per 100,000 population. Rates in the UK were higher still, 2.9/100,000, elevated by an upsurge in disease in injecting drug users. Rates from these northern countries were reasonably close to those observed in the USA and Australia during this period. In contrast, rates of reports in the more central and southern countries (Czech Republic, Romania, Cyprus and Italy) were substantially lower, 0.3 to 1.5 per 100,000 population, a possible reflection of poorer uptake of microbiological diagnostic methods within these countries.
Analysis of project data brought some new insights into risk factors for severe S. pyogenes infection, especially the importance of injecting drug users in the UK, with infections in this group fundamentally reshaping the epidemiology of these infections during this period. Analysis of additional data from the UK found use of NSAIDs (nonsteroidal anti-inflammatory drugs) to be significantly associated with development of streptococcal toxic shock syndrome (STSS), This research is providing us with valuable information surrounding the role of NSAIDs in the development of severe disease.
Several other novel findings arose through this work, including the high degree of congruence in seasonal patterns between countries and the seasonal changes in case fatality rates.
As a largely community-acquired infection, occurring sporadically and diffusely throughout the population, opportunities for control of severe infections caused by S. pyogenes remain limited, primarily involving contact chemoprophylaxis where clusters arise. Analysis of UK Strep-EURO data were used to quantify the risk to household contacts of cases, forming the basis of UK guidance on the management of contacts, the first developed by any country in Europe.Theresa Lamagni, one of the principal investigators for the project said,
“The research builds on our previous understanding of severe streptococcal infections and will be invaluable in the development of possible vaccines against these diseases.”
Paivi Lehtinen | alfa
Further reports about: > A streptococcus > Analysis > Health > Insights > NSAIDs > Protection > Risk > S. pyogenes infection > Skin infections > Strep-EURO > Streptococcus pyogenes > across > anti-inflammatory drug > factors > necrotising fasciitis > novel therapeutic targets > pyogenes > risk factor > risk of disease > scarlet fever > septicaemia > severe
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences